Kristina V. Orlova, Vadim Kozlov, Vladimir Moiseyenko, Ilya Pokataev, Mikhail Fedyanin, Irina Shumskaya, Svetlana Ogorodnikova, Anastasia V. Zimina, Svetlana Odintsova, Nadezhda Vitalievna Kovalenko, Konstantin Penkov, Sviatlana A. Dziamidava, Ruslan Zukov, Nikolai Ermakov, Vitaly Volkov. "A phase III randomized study comparing BCD-201, a pembrolizumab biosimilar candidate, and reference pembrolizumab in patients with advanced melanoma.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.9541